Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

E-ISSN： 1875-6212|8|6|820-830

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.8, Iss.6, 2010-11, pp. : 820-830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Effects of Current and Future Anti-Obesity Drugs

Current Vascular Pharmacology, Vol. 12, Iss. 3, 2014-01 ,pp. : 493-504

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid‐Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?

By Kostapanos Michael S Mikhailidis Dimitri P Elisaf Moses S

Future Cardiology, Vol. 8, Iss. 6, 2012-11 ,pp. : 813-817

Future Medicine

Access to resources Recommend Favorite

Target achievement with maximal statin‐based lipid‐lowering therapy in Korean patients with familial hypercholesterolemia: A study supported by the Korean Society of Lipid and Atherosclerosis

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1291-1296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Lipid-Lowering Drugs on Adiponectin

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 836-848

Bentham Science Publishers

Access to resources Recommend Favorite